Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study

S. Bavcar, J. De Vos, M. Kessler, P. De Fornel, P. Buracco, S. Murphy, J. Hirschberger, David Argyle

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study'. Together they form a unique fingerprint.

Veterinary Science and Veterinary Medicine